New hope for ulcerative colitis: experimental drug enters testing
NCT ID NCT07463183
Summary
This study is testing whether an experimental drug called MK-8690 can help adults with moderate-to-severe ulcerative colitis. About 100 participants will receive either the drug or a placebo for 12 weeks to see if it reduces bowel inflammation and symptoms like frequent stools and bleeding. The main goal is to see if more people taking MK-8690 achieve clinical remission compared to those taking the placebo.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ULCERATIVE COLITIS are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.